Datasheet1_Case Report: C-reactive protein apheresis in non-ST-elevation ACS—case series from the C-reactive protein apheresis in Acute Myocardial Infarction Registry.pdf

C-reactive protein (CRP) apheresis has been introduced in ST-elevation myocardial infarction and cardiogenic shock. Here, we describe a first-in-man application in non-ST-elevation acute coronary syndrome (NSTE-ACS). Seven NSTE-ACS patients with high CRP levels (range 14.2–154 mg/L) were treated with CRP apheresis. Treatment was well-tolerated. Patients were discharged in good clinical condition.